hoe 694 has been researched along with 5-(n,n-hexamethylene)amiloride in 1 studies
Studies (hoe 694) | Trials (hoe 694) | Recent Studies (post-2010) (hoe 694) | Studies (5-(n,n-hexamethylene)amiloride) | Trials (5-(n,n-hexamethylene)amiloride) | Recent Studies (post-2010) (5-(n,n-hexamethylene)amiloride) |
---|---|---|---|---|---|
120 | 0 | 4 | 145 | 0 | 34 |
Protein | Taxonomy | hoe 694 (IC50) | 5-(n,n-hexamethylene)amiloride (IC50) |
---|---|---|---|
Urokinase-type plasminogen activator | Homo sapiens (human) | 2.4 | |
Adenosine receptor A2a | Homo sapiens (human) | 2.685 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.27 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demaurex, N; Park, KS; Poburko, D; Wollheim, CB | 1 |
1 other study(ies) available for hoe 694 and 5-(n,n-hexamethylene)amiloride
Article | Year |
---|---|
Amiloride derivatives induce apoptosis by depleting ER Ca(2+) stores in vascular endothelial cells.
Topics: Amiloride; Antigens, Differentiation; Apoptosis; Calcium; Cell Cycle Proteins; Diuretics; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endothelial Cells; Enzyme Inhibitors; Guanidines; HeLa Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Protein Phosphatase 1; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Hydrogen Exchangers; Sulfones; Thapsigargin; Transcription Factor CHOP; Transcription, Genetic | 2009 |